Triatomic Management’s Aehr Test Systems AEHR Stock Holding History

Triatomic Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70,000	Closed	-$2.17M	–	54
2023 Q1	$2.17M	Buy	+70,000	New	+$2.25M	1.46%	14

Other funds holding AEHR

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Triatomic Management's AEHR Position: Q3 2023 in Review

Triatomic Management sold out of Aehr Test Systems (AEHR) in Q3 2023, closing a stake of 5,010 shares — an estimated $207K sold.

Triatomic Management first reported a position in AEHR in Q4 2022 and held it in 3 quarters. The position peaked at $648K in Q1 2023. 153 funds tracked by Wall St. Rank hold AEHR as of Q3 2023.

Triatomic Management reported no remaining Aehr Test Systems position as of Q3 2023 after selling out during the quarter.
Triatomic Management sold 5,010 Aehr Test Systems shares in Q3 2023, an estimated $207K.
Triatomic Management first reported a position in Aehr Test Systems in Q4 2022 and held it in 3 quarters.
Triatomic Management's Aehr Test Systems position peaked at $648K in Q1 2023.
153 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2023.

Based on Triatomic Management's 13F filing for Q3 2023, filed 3 Nov 2023.